3,067 Shares in Humana Inc. $HUM Purchased by Two Sigma Securities LLC

Posted by Brenda Bartman on Sep 1st, 2026

Two Sigma Securities LLC acquired a new position in shares of Humana Inc. (NYSE:HUM – Free Report) during the 2nd quarter, Holdings Channel reports. The fund acquired 3,067 shares of the insurance provider’s stock, valued at approximately $1,218,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Manning & Napier Advisors LLC bought a new stake in Humana in the second quarter worth $1,412,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in Humana by 4.1% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock valued at $66,207,000 after acquiring an additional 9,960 shares during the last quarter. Sustainable Insight Capital Management LLC raised its stake in shares of Humana by 23.7% in the fourth quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock valued at $6,341,000 after acquiring an additional 4,740 shares during the period. Pzena Investment Management LLC purchased a new stake in shares of Humana in the second quarter valued at $1,749,014,000. Finally, Swedbank AB lifted its holdings in shares of Humana by 6.2% in the 4th quarter. Swedbank AB now owns 111,803 shares of the insurance provider’s stock worth $28,636,000 after acquiring an additional 6,534 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Price Performance

NYSE HUM opened at $384.25 on Tuesday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The firm’s 50 day moving average price is $386.07 and its 200-day moving average price is $290.60. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88. The company has a market cap of $46.14 billion, a PE ratio of 36.35, a P/E/G ratio of 2.20 and a beta of 0.72.

Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. The firm had revenue of $40.89 billion during the quarter, compared to analysts’ expectations of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm’s quarterly revenue was up 26.2% on a year-over-year basis. During the same period in the prior year, the business posted $6.27 EPS. Sell-side analysts forecast that Humana Inc. will post 9.12 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently commented on HUM. Seaport Research Partners cut shares of Humana to a “neutral” rating in a research note on Wednesday, May 20th. Truist Financial increased their price objective on shares of Humana from $320.00 to $415.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Piper Sandler raised shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 price objective for the company in a research note on Thursday, July 30th. Evercore raised Humana from an “in-line” rating to an “outperform” rating and set a $480.00 target price on the stock in a research note on Wednesday, July 29th. Finally, Robert W. Baird set a $390.00 price target on Humana in a research note on Thursday, July 30th. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $403.91.

Check Out Our Latest Research Report on HUM

Humana Profile

(Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

3,067 Shares in Humana Inc. $HUM Purchased by Two Sigma Securities LLC

Humana Price Performance

Wall Street Analyst Weigh In

Humana Profile

Further Reading

You might be interested in: